Legal Representation
Attorney
Jong Park
USPTO Deadlines
Next Deadline
1424 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240102)
Due Date
January 02, 2030
Grace Period Ends
July 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
26 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 2, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jan 2, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Oct 17, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 17, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 27, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 8, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 29, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 29, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 26, 2023 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 14, 2023 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Mar 30, 2023 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Mar 30, 2023 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Mar 30, 2023 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Sep 30, 2022 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 30, 2022 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Sep 30, 2022 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Aug 30, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 29, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 29, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 26, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 26, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| May 26, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 19, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 7, 2021 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Oct 6, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 21, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of cells; medicines for human purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; living cells for medical purposes; living cells for veterinary purposes; cells, namely, chimeric antigen receptor T-cell (CAR-T), for medical purposes; pharmaceutical preparations for activating cellular function; preparations of microorganisms for medical purposes; biological preparations for medical or veterinary purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for tumor treatment; pharmaceutical preparations for health care, namely, pharmaceutical preparations for the treatment of cancer or immune disease; vaccines; colostral, murine, chimeric, humanized, human, monoclonal, and polyclonal antibodies for veterinary purposes; antibodies for medical purposes; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer or immune disease; pharmaceutical preparations for the treatment of cancers with T cells
Class 042
Product development in the field of cell therapy; research relating to pharmaceuticals; pharmaceutical drug development services; research and development of pharmaceuticals; research and development of vaccines; cell separation research services; biomedical research services; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; genetic testing, namely, biological information check, for medical research use; product development, namely, biologics development; research in the field of biologics; biological analysis; biological research; research in the field of gene analysis; genetic research; consultancy in the field of analysis of biology sequence processing for medical research purposes; multiple nucleotide sequence analysis for scientific research purposes; DNA sequence analysis for scientific research purposes
Additional Information
Design Mark
The mark consists of a circle design having three sections with colors of purple, orange and red and the word of "Karratio" in red.
Color Claim
The color(s) purple, orange and red is/are claimed as a feature of the mark.
Classification
International Classes
005
042